PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing

Howard D. Grimes; Gabriela F. Ciocarlie; Bo Yu; Duminda Wijesekera; Greg Shannon; Wayne Austad; Charles Fracchia; Dongyan Xu; Thomas R. Kurfess; Lisa Strama; Michael Mylrea; Bill Reid

doi:10.1109/MSEC.2022.3160465

PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing

Howard D. Grimes
, Gabriela F. Ciocarlie
, Bo Yu
, Duminda Wijesekera
, Greg Shannon
, Wayne Austad
, Charles Fracchia
, Dongyan Xu
, Thomas R. Kurfess
, Lisa Strama
, Michael Mylrea
, Bill Reid

Department of Computer Science

University of Texas at San Antonio
George Mason University
Idaho National Laboratory
Purdue University
Georgia Institute of Technology
National Center for Manufacturing Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Therefore, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.

Original language	English
Pages (from-to)	53-65
Number of pages	13
Journal	IEEE Security and Privacy
Volume	20
Issue number	6
DOIs	https://doi.org/10.1109/MSEC.2022.3160465
State	Published - 2022

Access to Document

10.1109/MSEC.2022.3160465

Cite this

@article{5a9ca9d47a8940b1bbfafbb07f8720d8,

title = "PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing",

abstract = "Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Therefore, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.",

author = "Grimes, \{Howard D.\} and Ciocarlie, \{Gabriela F.\} and Bo Yu and Duminda Wijesekera and Greg Shannon and Wayne Austad and Charles Fracchia and Dongyan Xu and Kurfess, \{Thomas R.\} and Lisa Strama and Michael Mylrea and Bill Reid",

note = "Publisher Copyright: {\textcopyright} 2003-2012 IEEE.",

year = "2022",

doi = "10.1109/MSEC.2022.3160465",

language = "English",

volume = "20",

pages = "53--65",

number = "6",

}

TY - JOUR

T1 - PURE Biomanufacturing

T2 - Secure, Pandemic-Adaptive Biomanufacturing

AU - Grimes, Howard D.

AU - Ciocarlie, Gabriela F.

AU - Yu, Bo

AU - Wijesekera, Duminda

AU - Shannon, Greg

AU - Austad, Wayne

AU - Fracchia, Charles

AU - Xu, Dongyan

AU - Kurfess, Thomas R.

AU - Strama, Lisa

AU - Mylrea, Michael

AU - Reid, Bill

PY - 2022

Y1 - 2022

N2 - Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Therefore, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.

AB - Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Therefore, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.

UR - https://www.scopus.com/pages/publications/85131767337

UR - https://www.scopus.com/pages/publications/85131767337#tab=citedBy

U2 - 10.1109/MSEC.2022.3160465

DO - 10.1109/MSEC.2022.3160465

M3 - Article

AN - SCOPUS:85131767337

SN - 1540-7993

VL - 20

SP - 53

EP - 65

JO - IEEE Security and Privacy

JF - IEEE Security and Privacy

IS - 6

ER -

PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing

Abstract

Access to Document

Other files and links

Fingerprint

Cite this